Literature DB >> 1707027

Immune response of peripheral blood mononuclear cells to HBx-antigen of hepatitis B virus.

M C Jung1, M Stemler, T Weimer, U Spengler, J Döhrmann, R Hoffmann, D Eichenlaub, J Eisenburg, G Paumgartner, G Riethmüller.   

Abstract

The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg. We have investigated whether this antigen is a target structure for human T-lymphocytes. Using recombinant HBxAg protein, we found HBxAg-specific stimulation of peripheral blood mononuclear cells in patients with acute hepatitis B virus infection (6 of 6) and chronic hepatitis B virus infection (6 of 17) but not in healthy individuals. With HBxAg-specific synthetic polypeptides, several T-cell epitopes were identified. Most were located in the carboxyterminal half of the HBxAg protein. Five T-cell clones specific for a T-cell epitope located at the carboxyterminal region of HBxAg were established and found to belong to the CD2/CD4-positive, CD8-negative subtype. These data establish for the first time HBxAg as an antigen in the cellular immune response.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1707027

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

1.  Deficiencies in the acute-phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation.

Authors:  Stephan Menne; Carol A Roneker; Michael Roggendorf; John L Gerin; Paul J Cote; Bud C Tennant
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection.

Authors:  Carolina Boni; Paola Fisicaro; Caterina Valdatta; Barbara Amadei; Paola Di Vincenzo; Tiziana Giuberti; Diletta Laccabue; Alessandro Zerbini; Albertina Cavalli; Gabriele Missale; Antonio Bertoletti; Carlo Ferrari
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

Review 3.  Hepatitis B virus infection and primary hepatocellular carcinoma.

Authors:  M Feitelson
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

4.  Comprehensive regression analysis of hepatitis B virus X antigen level and anti-HBx antibody titer in the sera of patients with HBV infection.

Authors:  József Pál; Zoltán Nyárády; Ilona Marczinovits; Alajos Pár; Younes Saleh Ali; György Berencsi; Krisztián Kvell; Péter Németh
Journal:  Pathol Oncol Res       Date:  2006-03-23       Impact factor: 3.201

5.  Inducible interleukin 32 (IL-32) exerts extensive antiviral function via selective stimulation of interferon λ1 (IFN-λ1).

Authors:  Yongkui Li; Jiajia Xie; Xiupeng Xu; Li Liu; Yushun Wan; Yingle Liu; Chengliang Zhu; Ying Zhu
Journal:  J Biol Chem       Date:  2013-05-31       Impact factor: 5.157

Review 6.  Immune-Escape Hepatitis B Virus Mutations Associated with Viral Reactivation upon Immunosuppression.

Authors:  Ivana Lazarevic; Ana Banko; Danijela Miljanovic; Maja Cupic
Journal:  Viruses       Date:  2019-08-24       Impact factor: 5.048

7.  Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength.

Authors:  Monique T A de Beijer; Diahann T S L Jansen; Yingying Dou; Wim J E van Esch; Juk Yee Mok; Mariëlle J P Maas; Giso Brasser; Robert A de Man; Andrea M Woltman; Sonja I Buschow
Journal:  J Virol       Date:  2020-03-17       Impact factor: 5.103

Review 8.  CD4+ T Cells in Chronic Hepatitis B and T Cell-Directed Immunotherapy.

Authors:  Sonja I Buschow; Diahann T S L Jansen
Journal:  Cells       Date:  2021-05-06       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.